A six-month animal study verifies the in vivo bioefficacy and biostability of the implant in the intraocular environmentwithnosurgicalorpostoperativecomplications.Preliminary ex vivo experimental results verify the IOP sensing feasibility of such device. This sensor will ultimately be implanted at the pars plana or on the iris of the eye to fulfill continuous, convenient, direct, and faithful IOP monitoring.